Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Please refer to Table I for details (8292)
Robinson PC, Richards D, Tanner HL et al (2020) Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
The options may be chosen on the product page Quick View Price range: $39.60 through $581.40 This product has multiple variants
A similar strategy has shown to improve disease outcomes compared to conventional follow-up in patients with RA [116,117,118] and PsA [119], while its value is still under debate in AxSpA [120]
REICK2 and REICK1 vs
US$ 22.95
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 24.81
US$ 23.77
